Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CIDR_NIA Study of Women's Health Across the Nation (SWAN) Repository

ABSTRACT: CIDR_NIA Study of Women's Health Across the Nation (SWAN) Repository

PROVIDER: PRJNA414498 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

CIDR_NIA Study of Women's Health Across the Nation (SWAN) Repository

Project description:CIDR_NIA Study of Women's Health Across the Nation (SWAN) Repository

| PRJNA414499 | ENA

Study of Women's Health Across the Nation (SWAN) Repository

Project description:<p>The Study of Womens Health Across the Nation (SWAN) is an active multi-site, multi-disciplinary, longitudinal study of women's health. Initially funded in 1994 by the National Institute on Aging (NIA), the National Institute of Nursing Research (NINR), and the Office of Research on Women's Health (ORWH), the overall goal of SWAN is to describe the natural history of the menopausal transition and the post menopause including biological, behavioral, and psychosocial characteristics. SWAN focuses on the impact of menopause on age-related chronic diseases, such as diabetes, cardiovascular disease, depression, bone loss and osteoporosis, as well as physical and cognitive functioning. SWAN has seven clinical study sites located in six states, two in California, and one each in Chicago, Boston, Detroit area, northern New Jersey and Pittsburgh. The SWAN cohort was recruited from these areas and consists of 3,302 African American, Caucasian, Chinese American, Hispanic and Japanese American women. SWAN participants were enrolled in 1996-1997 and have been seen annually or bi-annually for clinic visits, which include interviews, measurements, and the collection of blood and urine samples. SWAN participants have now been seen for the baseline and 15 follow-up visits.</p>

| phs001470 | dbGaP

Women's Health Study Accelerometer Data

Project description:Women's Health Study Accelerometer Data

| PRJNA601249 | ENA

Women's Health Study Accelerometer Data

Project description:Women's Health Study Accelerometer Data

| PRJNA601248 | ENA

NHLBI TOPMed: The Women's Health Initiative

Project description:NHLBI TOPMed: The Women's Health Initiative

| PRJNA352302 | ENA

Women's Health Initiative Clinical Trial and Observational Study - Imaging

Project description:Women's Health Initiative Clinical Trial and Observational Study - Imaging

| PRJNA1179517 | ENA

Women's Health Initiative Clinical Trial and Observational Study - Imaging

Project description:Women's Health Initiative Clinical Trial and Observational Study - Imaging

| PRJNA1179518 | ENA

Mental Health Intervention Research Center (MHIRC) DNA Repository

Project description:Mental Health Intervention Research Center (MHIRC) DNA Repository

| PRJNA507063 | ENA

Mental Health Intervention Research Center (MHIRC) DNA Repository

Project description:Mental Health Intervention Research Center (MHIRC) DNA Repository

| PRJNA507064 | ENA

Urinary metals and adipokines in midlife women: The Study of Women's Health Across the nation (SWAN).

Project description:BackgroundInformation on the associations between metal exposures and adipokines in human populations is limited and results are inconsistent. We evaluated the associations between metals and adipokines.MethodsUrinary concentrations of 15 metals (arsenic, barium, cadmium, cobalt, cesium, copper, mercury, manganese, molybdenum, nickel, lead, antimony, tin, thallium, and zinc) were measured in 1999-2000 among 1228 women of the Study of Women's Health Across the Nation Multi-Pollutant Study. Serum adipokines including high molecular weight (HMW)-adiponectin, leptin, and soluble leptin receptor (sOB-R) were measured at the follow-up visit (2002-2003). Linear regression models with adaptive elastic-net (AENET) were fit to identify metals associated with adipokines and to compute estimated percent changes in adipokines for one standard deviation increase in log-transformed urinary metal concentrations.ResultsAfter adjustment for confounders, urinary molybdenum was associated with a 5.54% higher level (95% CI: 1.36%, 9.90%), whereas cadmium was associated with a 4.53% lower level (95% CI: -8.17%, -0.76%) of HMW-adiponectin. Urinary molybdenum was also associated with a 5.95% lower leptin level (95% CI: -10.15%, -1.56%) and a 2.98% (95% CI: 0.69%, 5.32%) higher sOB-R level. Urinary cesium and lead were associated with a 3.58% (95% CI: -6.06%, -1.03%) and a 2.53% (95% CI: -4.80%, -0.21%) lower level of sOB-R, respectively.ConclusionsOur findings suggest that molybdenum was associated with favorable profiles of HMW-adiponectin, leptin, and sOB-R. Exposures to cadmium, cesium, and lead were associated with adverse adipokine profiles.

| S-EPMC8093324 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data